To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Patient Power
When cells in the stomach or esophagus lining begin to develop characteristics similar to cells of the small intestine, intestinal metaplasia has begun. This is a precancerous condition that, if not treated, puts patients at a higher risk of esophageal or gastric cancer. Wasif Saif, M.D., MBBS, medical oncologist, co-leader of the Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team (MDT), and leader of the Phase I Clinical Trials MDT at Karmanos, helped explain the connection of intestinal metaplasia to both cancers and some of the risk factors that lead to this precancerous condition.
Read the article here.